Trademark Overview
On Friday, January 2, 2026, a trademark application was filed for SHOULDERSCAP+ with the United States Patent and Trademark Office. The USPTO has given the SHOULDERSCAP+ trademark a serial number of 79451670. The federal status of this trademark filing is NON-FINAL ACTION COUNTED - NOT MAILED as of Wednesday, June 17, 2026. This trademark is owned by Stefan Bauer. The SHOULDERSCAP+ trademark is filed in the Computer & Software Products & Electrical & Scientific Products, Advertising, Business and Retail Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Computer software used by healthcare professionals for analyzing the results of medical and surgical interventions; electronic questionnaires of outcomes reported by patients; downloadable software in the nature of mobile applications providing access to information, advice and tools for calculating and evaluating performance in the fields of health care services, medical treatments, prosthetic surgery and patient care; downloadable electronic publications; recorded computer software for clinical decision support systems using digital twin technology for simulation and 3D measurement and planning processes; computer simulation software for 3D inspection, validation, analysis and reporting.
Collection of genetic, medical, biomedical, biological, chemical and biochemical information and data; compilation of statistical data for use in scientific or medical research; automatic processing of medical data.
Providing temporary use of non-downloadable computer software (SaaS software) to healthcare and healthcare professionals for analyzing results of medical and surgical procedures; software as a service enabling clinical decision support using digital twin technology; hosting of a platform (PaaS) for medical data analysis enabling the planning of personalized treatments using digital twins for research, innovation and improvement of therapeutic methods.
Medical tests for patient diagnosis and treatment, aimed at evaluating the outcomes of medical treatments and improving clinical diagnosis; medical analysis services, via a platform (PaaS), enabling the planning of personalized treatments using digital twins for research, innovation and improvement of therapeutic methods.
